Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-18

Clinical Trial Update: Adipose-derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update of adipose-derived mesenchymal stem cells for acute respiratory distress syndrome; the status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adipose-derived mesenchymal stem cells

Snippet

Sponsor: Shaoxing Second Hospital | Conditions: ARDS | Phase 1 | Status: UNKNOWN